Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophies, Journal of Clinical Investigation, vol.120, issue.9, pp.3042-3053, 2010. ,
DOI : 10.1172/JCI42258
Identification of a Gene That Causes Primary Open Angle Glaucoma, Science, vol.275, issue.5300, pp.668-670, 1997. ,
DOI : 10.1126/science.275.5300.668
Inner Limiting Membrane Barriers to AAV-mediated Retinal Transduction From the Vitreous, Molecular Therapy, vol.17, issue.12, pp.2096-2102, 2009. ,
DOI : 10.1038/mt.2009.181
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814392
Changes in Adeno-Associated Virus-Mediated Gene Delivery in Retinal Degeneration, Human Gene Therapy, vol.21, issue.5, pp.571-578, 2010. ,
DOI : 10.1089/hum.2009.194
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143418
Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouse, Gene Therapy, vol.102, issue.7, pp.916-926, 2009. ,
DOI : 10.1038/gt.2009.61
Retinal cell type expression specificity of HIV-1-derived gene transfer vectors upon subretinal injection in the adult rat: influence of pseudotyping and promoter, The Journal of Gene Medicine, vol.43, issue.10, pp.1367-1374, 2005. ,
DOI : 10.1002/jgm.788
URL : https://hal.archives-ouvertes.fr/hal-00187439
Effective gene therapy with nonintegrating lentiviral vectors, Nature Medicine, vol.25, issue.3, pp.348-353, 2006. ,
DOI : 10.1038/nm1365
Gene therapy restores vision in a canine model of childhood blindness, Nature Genetics, vol.28, issue.1, pp.92-95, 2001. ,
DOI : 10.1038/ng0501-92
Functional and Behavioral Restoration of Vision by Gene Therapy in the Guanylate Cyclase-1 (GC1) Knockout Mouse, PLoS ONE, vol.361, issue.6, p.11306, 2010. ,
DOI : 10.1371/journal.pone.0011306.s001
Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutations, Gene Therapy, vol.72, issue.1, pp.117-131, 2010. ,
DOI : 10.1016/0278-4327(88)90025-9
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2804971
AAV-mediated gene therapy for retinal disorders: from mouse to man, Gene Therapy, vol.30, issue.11, pp.849-857, 2008. ,
DOI : 10.1167/iovs.06-1501
Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis, New England Journal of Medicine, vol.358, issue.21, pp.2231-2239, 2008. ,
DOI : 10.1056/NEJMoa0802268
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis, New England Journal of Medicine, vol.358, issue.21, pp.2240-2248, 2008. ,
DOI : 10.1056/NEJMoa0802315
Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial, Human Gene Therapy, vol.19, issue.10, pp.979-990, 2008. ,
DOI : 10.1089/hum.2008.107
Adenovirus vectormediated in vivo gene transfer into adult murine retina, Invest Ophthalmol Vis Sci, vol.35, pp.2535-2542, 1994. ,
Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium, Gene Therapy, vol.97, issue.4, pp.292-303, 2007. ,
DOI : 10.1038/sj.gt.3302861
EFFICIENT GENE TRANSFER TO RETINAL PIGMENT EPITHELIUM CELLS WITH LONG-TERM EXPRESSION, Retina, vol.25, issue.2, pp.193-201, 2005. ,
DOI : 10.1097/00006982-200502000-00013
Mouse Containing a Recessive PDE? Mutation, Investigative Opthalmology & Visual Science, vol.49, issue.10, pp.4278-4283, 2008. ,
DOI : 10.1167/iovs.07-1622
Macular recovery after retinal detachment, Acta Ophthalmologica Scandinavica, vol.178, issue.5, pp.597-605, 2006. ,
DOI : 10.1111/j.1600-0420.2006.00676.x
Success in sight: The eyes have it! Ocular gene therapy trials for LCA look promising, Gene Therapy, vol.15, issue.17, pp.1191-1192, 2008. ,
DOI : 10.1056/NEJMoa0802315
Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration, Molecular Therapy, vol.18, issue.3, pp.643-650, 2010. ,
DOI : 10.1038/mt.2009.277
Therapeutic targets in age-related macular disease, Journal of Clinical Investigation, vol.120, issue.9, pp.3033-3041, 2010. ,
DOI : 10.1172/JCI42437
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929720
The blood-ocular barriers: past, present, and future, Documenta Ophthalmologica, vol.32, issue.1-2, pp.149-157, 1997. ,
DOI : 10.1007/BF02569055
Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons, Molecular Therapy, vol.17, issue.7, pp.1187-1196, 2009. ,
DOI : 10.1038/mt.2009.71
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes, Nature Biotechnology, vol.94, issue.1, pp.59-65, 2009. ,
DOI : 10.1038/nbt.1515
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895694
Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice, Human Molecular Genetics, vol.20, issue.4, pp.681-693, 2011. ,
DOI : 10.1093/hmg/ddq514
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN, Nature Biotechnology, vol.9, issue.3, pp.271-274, 2010. ,
DOI : 10.1038/nbt.1610
Systemic Delivery of scAAV9 Expressing SMN Prolongs Survival in a Model of Spinal Muscular Atrophy, Science Translational Medicine, vol.28, issue.3, pp.35-42, 2010. ,
DOI : 10.1038/nbt.1610
Prospects for the gene therapy of spinal muscular atrophy, Trends in Molecular Medicine, vol.17, issue.5, pp.259-265, 2011. ,
DOI : 10.1016/j.molmed.2011.01.002
Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates, Molecular Therapy, vol.19, issue.6, pp.1058-1069, 2011. ,
DOI : 10.1038/mt.2011.72
A Potential Role of Distinctively Delayed Blood Clearance of Recombinant Adeno-associated Virus Serotype 9 in Robust Cardiac Transduction, Molecular Therapy, vol.19, issue.6, pp.1079-1089, 2011. ,
DOI : 10.1038/mt.2011.3
High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype Vectors, Molecular Therapy, vol.17, issue.3, pp.463-471, 2009. ,
DOI : 10.1038/mt.2008.269
Brn3a as a Marker of Retinal Ganglion Cells: Qualitative and Quantitative Time Course Studies in Nai?ve and Optic Nerve?Injured Retinas, Investigative Opthalmology & Visual Science, vol.50, issue.8, pp.3860-3868, 2009. ,
DOI : 10.1167/iovs.08-3267
Developmental expression of a novel murine homeobox gene (Chx10): Evidence for roles in determination of the neuroretina and inner nuclear layer, Neuron, vol.13, issue.2, pp.377-393, 1994. ,
DOI : 10.1016/0896-6273(94)90354-9
Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8, Molecular Therapy, vol.14, issue.1, pp.45-53, 2006. ,
DOI : 10.1016/j.ymthe.2006.03.014
Recombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In Vivo, Circulation Research, vol.99, issue.4, pp.3-9, 2006. ,
DOI : 10.1161/01.RES.0000237661.18885.f6
Analysis of AAV Serotypes 1???9 Mediated Gene Expression and Tropism in Mice After Systemic Injection, Molecular Therapy, vol.16, issue.6, pp.1073-1080, 2008. ,
DOI : 10.1038/mt.2008.76
Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration, Gene Therapy, vol.14, issue.22, pp.1605-1609, 2007. ,
DOI : 10.1089/hum.2006.17.601
Neonatal systemic delivery of scAAV9 in rodents and large animals results in gene transfer to RPE cells in the retina, Experimental Eye Research, vol.93, issue.4, pp.491-502, 2011. ,
DOI : 10.1016/j.exer.2011.06.012
Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system, The FASEB Journal, vol.25, issue.10, pp.3505-3518, 2011. ,
DOI : 10.1096/fj.11-182311
Enhanced gene delivery to the neonatal retina through systemic administration of tyrosine-mutated AAV9, Gene Therapy, vol.184, issue.2, 2011. ,
DOI : 10.1038/nprot.2006.207
GFAP-Driven GFP Expression in Activated Mouse M?ller Glial Cells Aligning Retinal Blood Vessels Following Intravitreal Injection of AAV2/6 Vectors, PLoS ONE, vol.15, issue.8, p.12387, 2010. ,
DOI : 10.1371/journal.pone.0012387.s001
AAV8, 9, Rh10, Rh43 Vector Gene Transfer in the Rat Brain: Effects of Serotype, Promoter and Purification Method, Molecular Therapy, vol.16, issue.1, pp.89-96, 2008. ,
DOI : 10.1038/sj.mt.6300331
Transgenic Mice Expressing Cyan Fluorescent Protein as a Reporter Strain to Detect the Effects of Rotenone Toxicity on Retinal Ganglion Cells, Journal of Toxicology and Environmental Health, Part A, vol.21, issue.2, pp.1582-1592, 2008. ,
DOI : 10.1007/BF03033307
Myocilin and glaucoma: facts and ideas, Progress in Retinal and Eye Research, vol.21, issue.4, pp.395-428, 2002. ,
DOI : 10.1016/S1350-9462(02)00010-1
Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice, Genetic Vaccines and Therapy, vol.6, issue.1, p.13, 2008. ,
DOI : 10.1186/1479-0556-6-13
Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes, Gene Therapy, vol.8, issue.17, pp.1323-1332, 2001. ,
DOI : 10.1038/sj.gt.3301529
Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector, Proceedings of the National Academy of Sciences, vol.9, issue.1, pp.10319-10323, 1997. ,
DOI : 10.1016/0896-6273(92)90226-4
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC23360/pdf
Usher syndrome: Animal models, retinal function of Usher proteins, and prospects for gene therapy, Vision Research, vol.48, issue.3, pp.433-441, 2008. ,
DOI : 10.1016/j.visres.2007.08.015
Gene therapy prevents photoreceptor death and preserves retinal function in a Bardet-Biedl syndrome mouse model, Proceedings of the National Academy of Sciences, vol.13, issue.6, pp.6276-6281, 2011. ,
DOI : 10.1016/j.ymthe.2006.03.005
Bevacizumab as a Potent Inhibitor of Inflammatory Corneal Angiogenesis and Lymphangiogenesis, Investigative Opthalmology & Visual Science, vol.48, issue.6, pp.2545-2552, 2007. ,
DOI : 10.1167/iovs.06-0570
The role of the posterior ciliary body in the biosynthesis of vitreous humour, Eye, vol.16, issue.4, pp.454-460, 2002. ,
DOI : 10.1038/sj.eye.6700199